panbela therapeutics宣佈第三次獨立安全審查通過，Phase 3 Asp

快訊 · 06/24 20:00

Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 Aspire Clinical Trial Dsmb Recommended Continuation With No Trial Modification

panbela therapeutics宣佈第三次獨立安全審查通過，Phase 3 Aspire臨床試驗DSMB推薦繼續進行，無需修改試驗。